Predictors of lung adenocarcinoma with leptomeningeal metastases: A 2022 targeted-therapy-assisted molGPA model
Frontiers in Oncology
Open Access Publication
Rights and Permissions
Zhang M, Tong J, Ma W, Luo C, Liu H, Jiang Y, Qin L, Wang X, Yuan L, Zhang J, Peng F, Chen Y, Li W and Jiang Y (2022) Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model. Front. Oncol. 12:903851. doi: 10.3389/fonc.2022.903851 © 2022 Zhang, Tong, Ma, Luo, Liu, Jiang, Qin, Wang, Yuan, Zhang, Peng, Chen, Li and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Zhang, Milan; Tong, Jiayi; Ma, Weifeng; Luo, Chongliang; Liu, Huiqin; Jiang, Yushu; Qin, Lingzhi; Wang, Xiaojuan; Yuan, Lipin; Zhang, Jiewen; Peng, Fuhua; Chen, Yong; Li, Wei; and Jiang, Ying, "Predictors of lung adenocarcinoma with leptomeningeal metastases: A 2022 targeted-therapy-assisted molGPA model." Frontiers in Oncology. 12, 903851 (2022).